Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Share-based Compensation for 4 consecutive years, with $36.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 9.09% year-over-year to $36.0 million, compared with a TTM value of $130.0 million through Dec 2025, up 4.0%, and an annual FY2025 reading of $130.0 million, up 4.0% over the prior year.
  • Share-based Compensation was $36.0 million for Q4 2025 at GE HealthCare Technologies, down from $38.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $38.0 million in Q3 2025 and bottomed at $9.0 million in Q4 2022.
  • Average Share-based Compensation over 4 years is $27.2 million, with a median of $28.5 million recorded in 2023.
  • The sharpest move saw Share-based Compensation soared 266.67% in 2023, then crashed 35.29% in 2025.
  • Year by year, Share-based Compensation stood at $9.0 million in 2022, then skyrocketed by 266.67% to $33.0 million in 2023, then changed by 0.0% to $33.0 million in 2024, then grew by 9.09% to $36.0 million in 2025.
  • Business Quant data shows Share-based Compensation for GEHC at $36.0 million in Q4 2025, $38.0 million in Q3 2025, and $34.0 million in Q2 2025.